Abstract
Biological response modifiers have multiple biological effects. Therefore, results obtained in vitro cannot be directly extrapolated to the therapeutic efficacy in humans. So animal studies are an essential prerequisite for the successful application of these agents in man. Interferons show a high degree of species specificity. Human interferon preparations are not active in “standard” laboratory animals as rats and mice. For studies in these species interferons from rat and mouse origin have to be produced. Initially the rodent interferons were produced from induced cell culture systems, which did not provide enough material for all the necessary studies. Recombinant DNA technology did not only solve the problem of production of human interferon, but also a number of animal interferons can now be produced in unlimited amounts (1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schellekens, H. and Meide, P.H. van der. In: The Interferon System, a current review (Baron et al., eds.), The University of Texas Press, 1987, in press.
Andrews, R.D. Brit. Med. J. 1728: 1728–1730, 1961.
Falcoff, R., Falcoff, E., Duboche, P. et Chany, C. CR. Acad. Sc. Paris, t. 266, Série D: 297–300, 1968.
Pinto, CA., Haff, R.F., Valenta, J.R., Pagano, J.F., DiCuollo, C.J. and Ferlauto, R.J., In: Symp. Series Immunobiol. Standard., vol. 14: 105–112, Karger, Basel/New York, 1970.
Neumann-Haefelin, D., Sundmacher, R., Sauter, B., Karges, H.E. and Manthey, K.F. Infection and Immunity 12, no. 1: 148–155, 1975.
Neumann-Haefelin, D., Shrestha, B. and Manthey, K.F. J. Infect. Dis. 133: A211-A216, 1976.
Schellekens, H., Weimar, W., Cantell, K. and Stitz, L. Nature 278: 742, 1979.
Schellekens, H., Stitz, L.W., Reus, A. de, Weimar, W. and Cantell, K. Antiviral Res. 1: 281–285, 1981a.
Schellekens, H., Reus, A. de, Bolhuis, R., Fountoulakis, M., Schein, C, Ecsödi, J., Nagata, S. and Weissmann, C. Nature 292:775–776, 1981b.
Weimar, W., Stitz, L., Billiau, A., Cantell, K. and Schellekens, H. J. gen. Virol. 48: 25–30, 1980.
Meide, P.H. van der, Harteveld, N., Stebbing, N. and Schellekens, H. Antiviral Res., suppl. 1: 199–207, 1985.
Finter, N.B. Interferons and interferon inducers. Elsevier Publishing company, Amsterdam, London, New York, 1973.
Hilfenhaus, J., Karges, H.E., Weinmann, E. and Barth, R. Infect. Imm. 11, no. 5: 1156–1158, 1975.
Hilfenhaus, J., Weinmann, E., Majer, M., Barth, R. and Jaeger, O. J. Infect. Dis. 135, no. 5: 846–849, 1977.
Bear, CM., Shaddock, J.H., Moore, S.A., Yager, P.A., Baron, S.S., Levy, H.B. J. Infect. Dis. 136, 286–291, 1977.
Arvin, A.M., Martin, D.P., Gard, E.A. and Merigan, T.C. J. Infect. Dis. 147, no. 1: 149–154, 1983.
Desmyter, J., Groote, J. de, Desmet, V.J., Ray, M.B., Bradburne, A.F., Edy, V.G., Somer, P. de and Mortelmans, J. Lancet 645–647, 1976.
Goeddel, D.V., Yelverton, E., Ullrich, A., Heyneker, H.L., Miozzari, G., Holmes, W., Seeburg, P.H., Dull, T., May, L., Stebbing, N., Crea, R., Maeda, S., McCandliss, R., Sloma, A., Tabor, J.M., Gross, M., Familletti, P.C. and Pestka, S. Nature 287: 411–416, 1980.
Week, P.K., Harkins, R.N. and Stebbing, N. J. gen. Virol. 64: 415–419, 1983.
Stebbing, N., Week, P.K., Fenno, J.T., Estell, D.A. and Rinderknecht, E. Arch. Virol. 76: 365–372, 1983.
Levin, R., Yaari, A., Gitelman, J., Bino, T., Rosenberg, H. and Kohn, A. Antiviral Res. 6: 277–283, 1986.
Sugar, J., Kaufman, H.E. and Varnell, E.D. Invest. Ophthalmol. 12: 378380, 1973.
Neumann-Haefelin, D., Sundmacher, R., Skoda, R. and Cantell, K. (1977) Infect. Imm. 17, no. 2: 468–470, 1977.
Neumann-Haefelin, D., Sundmacher, R., Frey, H. and Merk, W. Med. Microbiol. Immunol. 174; 81–86, 1985.
Ferreira, A., Schofield, L., Enea, V., Schellekens, H., Meide, P., Collins, W.E., Nussenzweig, R.S. and Nussenzweig, V. Science 232: 881–884, 1986.
Schellekens, H., Eerd, P.M.C.A. van, Reus, A. de, Weck, P.K. and Stebbing, N. Antiviral Res. 2: 313–318, 1982.
Soike, K.F., Kramer, M.J. and Gerone, P.J. J. Infect. Dis. 147, no. 5: 933–938, 1983.
Habif, D.V., Lipton, R. and Cantell, K. Proc. Soc. Exp. Biol. Med. 149, 287–289, 1975.
Wills, R.J., Spiegel, H.E. and Soike, K.F. J. Interferon Research 4, 399–409, 1984.
Collins, J.M., Riccardi, R., Trown, P., O’Neill, D. and Poplack, D.G. Cancer Drug Delivery 2, 247–253, 1985.
Skreko, F., Zajac, I., Bahnsen, H.P., Haff, R.F. and Cantell, K. Proc. Soc. Exper. Biol. Med. 142, 946–947, 1973.
Yamazaki, S., Kohase, M., Tatsumi, N., Onishi, E. et al. In: The clinical potential of interferons. Eds. R. Kono and J. Vilcek. Univ. Tokyo Press, pp. 281–293, 1981.
Bino, T., Edery, H., Gertler, A. and Rosenberg, H. J. gen. Virol. 59, 39–45, 1982.
Hilfenhaus, J., Damm, H., Hofstaetter, T., Mauler, R. et al. J. Interferon Res. 1, 427–436, 1981.
Gomi, K., Morimoto, M., Inoue, A., Kobayashi, H. et al. Gann 75., 292–300, 1984.
Edy, V.G., Billiau, A. and De Somer, P. Lancet i, 451–452, 1978.
Billiau, A., De Somer, P., Edy, V.G., De Clercq, E. and Heremans, H. Antimicr. Agents Chemother. 16, 56–63, 1979.
Vilcek, J., Sulea, I.T., Zerebreckyj, I.L. and Yip, Y.K. J. Clin. Microbiol. 11, 102–105, 1980.
Gutterman, J.U., Fine, S., Quesada, J., Horning, S.J. et al. Ann. Internal Med. 96, 549–556, 1982.
Cantell, K., Hirvonen, S., Pyhälä, L., De Reus, A. and Schellekens, H. J. gen. Virol. 64., 1823–1826, 1983.
Dawson, A., Hirsch, M., Otto, B., De Reus, A. and Schellekens, A. In: The biology of the interferon system. E. de Maeyer and H. Schellekens, eds., pp. 449–452, 1983.
Billiau, A., Heremans, H., Ververken, D., Van Damme, J., Carton, H. and De Somer, P. Archives of Virol. 68, 19–25, 1981.
Kurzrock, R., Rosenblum, M.G., Sherwin, S.A., Rios, A. et al. Cancer Res. 45, 2866–2872, 1985.
Pestka, S., Kelder, B., Familletti, P.C., Moschera, J.A. et al. J. Biol. Chem. 258, 9706–9709, 1983.
Finter, N.B., Woodrooffe, J. and Priestman, T.J.: Nature 298: 301, 1982.
Weissmann, C. and Schellekens, H.: Nature 298: 301, 1982.
Yamada, H., Nishiuchi, M., Sato, K., Kobayashi, F., Harada, Y., Bannai, H., Tatsumi, M. and Yamazaki, S. In: Interferons. Proc. of the Int. Symp. on Interferons (Kishida, T., ed.)278–285, 1984.
Schellekens, H.: In: Interferons, UCLA Symposia on Mol. and Cell. Biol. XXV (Merigan, T.C. et al., eds.), Academic Press, 1982, pp. 387–392.
Schellekens, H., Reus, A. de and Meide, P.H. v.d. J. Med. Primatol. 13: 235–245, 1984.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Schellekens, H., Van Der Meide, P.H., Nooter, K. (1988). Interferon Studies in Non-Human Primates. In: Revel, M. (eds) Clinical Aspects of Interferons. Developments in Medical Virology, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1737-1_22
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1737-1_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8977-7
Online ISBN: 978-1-4613-1737-1
eBook Packages: Springer Book Archive